The CryIVD protein is involved in the overall toxicity of the Bacillus thuringiensis subsp. israelensis parasporal inclusions and is one of the four major components of the crystals. Determination of the DNA sequence indicated that the cryIVD gene is the second gene of an operon which includes three genes. The first one encodes a 19-kDa polypeptide and has sequence homology with the orf1 gene of the Bacillus thuringiensis cryIIA and cryIIC operons. The second and third genes have already been identified and encode the CryIVD crystal protein and the P20 polypeptide, respectively. The promoter region was located by deletion analysis, and the 5 end of the mRNA was determined by primer extension mapping. Transcription of the cryIVD gene in B. thuringiensis subsp. israelensis strains is induced 9 h after the beginning of sporulation. Sequence analysis indicated two potential promoters, a strong one and a weak one, recognized respectively by the RNA polymerase associated with the 35 or the 28 factor of B. thuringiensis ( E and K of Bacillus subtilis, respectively). Transcriptional lacZ fusion integrated in single copy into the chromosome of various B. subtilis sporulation mutants confirmed the E dependence of cryIVD gene transcription.
Bacillus thuringiensis is a gram-positive soil bacterium which produces large amounts of entomocidal proteins that accumulate in the cytoplasm to form crystals. Bacillus thuringiensis subsp. israelensis inclusions are toxic to mosquito and blackfly larvae, which are vectors of several tropical diseases (18, 39) . B. thuringiensis subsp. israelensis crystals are composed of four major polypeptides with molecular masses of about 125, 135, 68, and 28 kDa, referred to as CryIVA, CryIVB, CryIVD, and CytA, respectively (21) ; their corresponding genes are located on a large conjugative resident plasmid with a size of 72 MDa (for a review, see reference 27). Synergistic interactions between the crystal components are responsible for the high toxicity of B. thuringiensis subsp. israelensis (15, 46) . Various proteins seem to be involved in the crystal's biosynthesis, which is coordinated with the sporulation process and is highly efficient (20% of the total cell proteins). A 20-kDa protein (P20) has been shown to increase CryIVD and CytA production in Escherichia coli by a posttranslational stabilization (40) , although its role in B. thuringiensis subsp. israelensis is subject to controversy (12, 47) . Most of the cloned B. thuringiensis toxin genes are monocistronic, although the two major toxin genes of B. thuringiensis subsp. thompsoni and the B. thuringiensis subsp. kurstaki cryIIA and cryIIC toxin genes are organized in operons (8, 44, 45) . The cryIIA and cryIIC genes are associated with two other genes, orf1 and orf2. Recently, Crickmore et al. (14) have shown that cloning the orf1 and orf2 genes of the cryIIA operon with the cryptic cryIIB protein gene allows the synthesis of CryIIB inclusions. The deletion of orf1 has no effect on the production of the CryIIA or CryIIC toxins in B. thuringiensis (13, 45) . However, crystallization of CryIIA requires the presence of the orf2 gene product, which is composed of a head-to-tail repetition of the same polypeptide fragment (13) . Both the P20 and Orf2 polypeptides may act as chaperone proteins to initiate, facilitate, or stabilize crystal formation.
In Bacillus subtilis, the first step of the sporulation process is controlled by the phosphorylated form of the Spo0A protein which activates or represses genes (6, 20) . In spo0A mutants, blocked at the first stage of the sporulation process, expression of the cry genes, except cryIIIA (2), is lost. These genes are therefore referred to as sporulation-specific genes (33) .
The temporal and compartmental control of the sporulation genes in B. subtilis are due to the activation of a cascade of specific sigma subunits of the RNA polymerase (for a review, see reference 30). To date, four sigma factors have been shown to be sporulation specific.
E and F are active in early stages after the formation of the septum, while G and K are produced after the engulfment of the forespore.
F and G are active in the forespore, and E and K are active in the mother cell. In B. thuringiensis, as in B. subtilis, various sigma factors have been identified. The RNA polymerase, associated with the 35 factor (a B. thuringiensis homolog of E ), recognizes promoters during early to midsporulation (9) . Associated with a second sigma factor, 28 (homologous to K ), it recognizes mid-to late-sporulation promoters (10) . In B. thuringiensis subsp. israelensis, the cryIVA and cryIVB promoters are activated in the midsporulation phase. Yoshisue et al. (49) showed by sequence homology that the cryIVA gene may be regulated by the 35 RNA polymerase, and recently they demonstrated that cryIVB was under the control of 35 (50) . In contrast, the cytA gene is transcribed from two promoters: pBtI (43), which is recognized by the RNA polymerase associated with 35 (9) , and pBtII (41) , which is regulated by the 28 RNA polymerase (10) .
No data about the regulation of cryIVD gene expression were available. We therefore sequenced the upstream region of the cryIVD gene. Two transcriptional start sites were identified, a major transcript corresponding to a promoter recognized by 35 and a minor transcript which could correspond to a promoter recognized by 28 . Transcriptional fusion in B. subtilis showed that the cryIVD gene was under the transcriptional control of E and also probably under the control of K .
We found a new open reading frame (ORF) (named p19), upstream from cryIVD, which could encode a putative 19-kDa polypeptide (referred to as P19). This polypeptide shows significant similarity with the Orf1 encoded by both the cryIIA and cryIIC operons.
MATERIALS AND METHODS
Bacterial strains. B. thuringiensis subsp. israelensis 4Q2-81 (kindly provided by D. H. Dean, Ohio State University, Columbus), an acrystalliferous strain cured of all resident plasmids, was used as the recipient strain for transformation experiments. 4Q2-81 was transformed by electroporation (26) , and transformants were selected on Luria-Bertani plates containing erythromycin (10 g/ml). The isogenic strain 4Q2-72 containing the plasmid encoding the toxins was used to extract total RNA. E. coli TG1 [⌬(lac-proAB) supE thi hdsD FЈ(traD36 proA ϩ proB ϩ lacI q lacZ⌬M15)] (34) and JJC242 (supE44 hsdR thi-1 thr-1 leuB6 lacY1 tonA21 dam) (provided by B. Michel, Institut National de la Recherche Agronomique, Jouy-en-Josas, France) were used for plasmid cloning. Cells were transformed as previously described (25) , and transformants were selected on ampicillin (100 g/ml).
The B. subtilis strains used in this work are listed in Table 1 . The different strains were transformed by plasmid or chromosomal DNA as previously described (4) and selected with appropriate antibiotics (chloramphenicol, kanamycin, or erythromycin, each at 10 g/ml). B. subtilis strains were grown in LuriaBertani medium or in nutrient broth sporulation medium (SP medium) (2) .
Plasmids. The shuttle vectors pHT304 (5), pHT304-18Z containing the lacZ gene (3), and pACYC184 (laboratory stock) were used for cloning experiments. Plasmid pEG217 (16) contains a 10-kb HindIII fragment which carries the cryIVD and the cytA genes. The plasmid pAC5 (28) containing the B. subtilis amyE locus was used for integration.
Plasmid pHT643, which carries the p19, cryIVD, and p20 genes was obtained by cloning the 4.1-kb ClaI-EcoRV DNA fragment from pEG217 into the SmaI site of pHT304 (see Fig. 4 ). The ClaI end was made blunt with Klenow fragment.
Plasmid pHT646 was obtained by cloning the 2.2-kb BspHI fragment from pEG217, blunt ended with Klenow fragment, into the SmaI site of pHT304 (see Fig. 4 ). This plasmid carries the cryIVD coding sequence without either the upstream region or the p20 gene.
To obtain pHT647, lacking the p20 gene, the 1.2-kb SacI-PvuII fragment from pHT646 and the 1.9-kb PvuII-HindIII fragment from plasmid pHT643 (see Fig.   4 ) were ligated into pHT304 restricted with SacI-HindIII. The intragenic PvuII site was thus restored in plasmid pHT647.
Plasmid pHT649 containing an internal deletion of the p19 gene and lacking the p20 gene was constructed in three steps. First, the 2-kb PvuII fragment of pHT643 (see Fig. 4 ) was cloned into pACYC184 restricted with PvuII, yielding pACYCcryIVDЈ. Second, plasmid pACYCcryIVDЈ (purified from strain JJC242, a dam strain) was cut by BspHI and religated, to yield plasmid pACYCcryIVDЈ ⌬BspHI lacking the 285-bp BspHI fragment corresponding to an internal deletion of the p19 gene. Finally, the 1.6-kb HindIII-PvuII fragment of pACYCcryIVDЈ ⌬BspHI was cloned together with the 1.2-kb PvuII-SacI fragment of pHT646 (see Fig. 4 ) in pHT304 restricted with HindIII-SacI. The intragenic PvuII site was thus restored in plasmid pHT649.
Plasmid pHT693 was obtained by inserting the 677-bp XmnI-HindIII fragment from pHT643 (see Fig. 4 ) into pHT304-18Z; pHT304-187 was digested with BamHI, treated with the Klenow fragment, and then digested with HindIII. pHT693 therefore contains a transcriptional fusion between the cryIVD promoter region and the lacZ gene.
Plasmid pBT10 was constructed as follows. pHT693 was restricted with HindIII, treated with Klenow fragment, and then digested with SacI. The resulting 2.6-kb fragment, carrying the cryIVDЈ-lacZ fusion, was cloned into pAC5 digested with SmaI and SacI, yielding pBT10. The cryIVDЈ-lacZ fusion was integrated into the chromosome of B. subtilis at the amyE locus by homologous recombination after linearization at the single ScaI restriction site. Recombinant cells were screened for the loss of amylase activity, and integration was confirmed by Southern blot experiments (37) .
The phage M13cryIVDЈ was constructed by cloning the 1.9-kb PvuII-HindIII fragment from pHT643, containing the promoter region of the cryIVD gene, into the plasmid M13mp19 digested with HindIII and SmaI.
DNA manipulation. Plasmid DNA was extracted from E. coli by the standard alkaline lysis procedure (7) . Restriction enzymes, T4 DNA ligase, and Klenow fragment were used as recommended by the manufacturers. The DNA fragments were purified from agarose gel with the Prep A Gene DNA purification matrix kit (Bio-Rad). Chromosomal DNA was extracted from B. subtilis as previously described (31) . The nick translation reactions were performed with the nick translation kit (Amersham, Buckinghamshire, United Kingdom) and [␣- Oligonucleotides were synthesized (Millipore, Inc., Burlington, Mass.) and used for amplification or sequencing reactions without purification.
PCRs were carried out by using the thermostable Thermus aquaticus DNA polymerase as recommended by the supplier (Amersham). Single-stranded DNA was obtained through asymmetric amplification (36) . DNA sequences were determined by using the dideoxy chain termination method (35) with a Sequenase version 2.0 kit (U.S. Biochemical Corp., Cleveland, Ohio) and ␣- Computer analysis was done by using the Genetics Computer Group sequence analysis software package programs (University of Wisconsin, Madison). The multiple alignment was obtained by using the CLUSTAL program.
RNA extraction and primer extension. Total RNA was isolated from 4Q2-72 cells grown in HCT medium (24) . Total RNA was extracted as previously described (17) . Elongation of the radioactive DNA primers by reverse transcriptase and analysis of the products were performed as previously described (11) Northern (RNA) blot. One hundred micrograms of total RNA was separated on a formaldehyde agarose gel containing ethidium bromide (2 g/ml) as previously described (34) . The gel was washed three times with water (5 min) and then for 45 min with 10ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The RNAs were transferred to a Hybond-N ϩ membrane (Amersham) under vacuum in 10ϫ SSC for 1 h and fixed to the membrane by heating in a vacuum oven for 2 h at 80ЊC. The membrane was prehybridized at 42ЊC for 1 h in 10 ml of 50% formamide-5ϫ SSC-0.5% sodium dodecyl sulfate (SDS)-0.02% Denhardt's solution. One milligram of salmon sperm DNA and 5 ϫ 10 7 cpm of ␣-32 P-labeled, nick translated probe (described in the legend to Fig. 8 ) were heat denatured for 10 min at 100ЊC, chilled on ice, and then added to the membrane in prehybridization buffer. The membrane was incubated with slow shaking for 18 h at 42ЊC and washed for 20 min at 42ЊC twice in 2ϫ SSC, twice in 2ϫ SSC-0.5% SDS-50% formamide, and finally twice in 0.1% SSC at 37ЊC. The membrane was exposed with an X-ray film (Amersham) at Ϫ70ЊC overnight or longer.
␤-Galactosidase assays. B. subtilis and B. thuringiensis subsp. israelensis cells containing the cryIVDЈ-lacZ fusion were grown in SP or HCT medium, respectively, supplemented with appropriate antibiotics. ␤-Galactosidase activity was determined as previously described (15, 29) .
RESULTS
Nucleotide sequence of the intergenic cytA-cryIVD region. Plasmid pEG217 (16) harbors a 10-kb HindIII fragment isolated from the B. thuringiensis subsp. israelensis strain HD567 (Fig. 1A) , carrying both the cytA and cryIVD genes plus adjacent and intergenic regions. It was used as a DNA template for 
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a The underlined resistance genes were used for selection in strain constructions: kan (kanamycin resistance), cat (chloramphenicol resistance), and mls (erythromycin resistance).
b For each construction, the arrows point to the recipient strains used in DNA transformation.
asymmetric PCR. The amplified intergenic region was sequenced on both strands (see Materials and Methods). The 1,660-bp sequence between the ATG of the cytA gene and the ATG of the cryIVD gene contains two 13-bp long repeats (5Ј-TTTGAAtAAGTTT-3Ј; Fig. 1B ) which are composed of head-to-head repeats of 6 bp. The role of these repeats remains to be determined.
The intergenic sequence was examined for ORFs. Only one ORF, encoding a putative polypeptide longer than 80 amino acids, was found. This ORF, designated p19, is in the same orientation as the cryIVD gene and begins at position 1081 and ends at position 1590 with a TAA stop codon (Fig. 1B) . A potential ribosome binding site (5Ј-GGAG-3Ј) was found 11 nucleotides upstream from the proposed ATG start codon. p19 potentially encodes a 170-amino-acid polypeptide with a calculated molecular mass of 18.8 kDa, named P19. No transcriptional termination signal was found between the p19 and cryIVD genes, which may therefore be organized as a single transcriptional unit.
A search for similarities with other known genes (EMBL data library) revealed that the p19 gene shares significant similarities only with the orf1 gene of the B. thuringiensis cryIIA operon (44) and with the orf1 gene of the B. thuringiensis cryIIC operon (45) . Sequence alignment (Fig. 2) indicated that p19 and both orf1 genes encode polypeptides exhibiting strong similarity in their central regions: there is 50% identity be-FIG. 1. Schematic restriction map of the 10-kb HindIII DNA fragment carrying the cryIVD and cytA genes (A) and nucleotide sequence of the intergenic region between the two genes (B). The amino acid sequences of the putative P19 polypeptide and of the beginning of the CryIVD polypeptides are indicated under the nucleotide sequence. The CytA amino acids are indicated above the sequence to illustrate the gene location on the complementary strand. Different elements are indicated: the 13-bp repeats (shaded boxes), the potential ribosome binding site (underlined), the pBtI promoter (bold and underlined), and the pBtII promoter (boldface and framed) with the two corresponding transcriptional start sites for the cytA gene, the MboII and RsaI sites, which allowed generation of the probes used for primer extension experiments and the two transcriptional start sites (PI and PII; boldface) described in this paper. The sequences of the two oligonucleotides used as primers for PCR amplification are (i) 5Ј-CGCAATAGTAGGTTCGG-3Ј (corresponding to the start of the coding sequence of the cryIVD, complementary to nucleotides 1790 to 1806) and (ii) 5Ј-CTCTATTACCTTTCTCAGGC-3Ј (corresponding to the promoter region of the cytA gene [42] , nucleotides 501 to 520). (Fig. 3) . Determination of the transcriptional start sites by primer extension and temporal regulation of the cryIVD gene in B. thuringiensis subsp. israelensis. The cryIVD gene promoter was mapped by sequential deletion analysis in B. thuringiensis subsp. israelensis. Various DNA fragments derived from the ClaI-EcoRV restriction fragment of pEG217 (Fig. 4) were cloned into pHT304 and reintroduced into the acrystalliferous strain 4Q2-81. CryIVD synthesis was checked by SDS-polyacrylamide gel electrophoresis (PAGE) analysis (data not shown). No cryIVD expression was obtained when the 659-bp EcoRV-BspHI fragment was deleted (Fig. 4 [plasmid pHT646] ), suggesting that this region is required for expression of the cryIVD gene. To determine whether p20 or p19 is necessary for the full expression of the cryIVD gene, plasmids pHT647 and pHT649 were constructed (Fig. 4) . The results obtained showed that neither p20 (Fig. 4 [compare pHT643 with pHT647]) nor p19 (Fig. 4 [compare pHT643 with pHT649]) was required for expression of the cryIVD gene in B. thuringiensis subsp. israelensis. Moreover, there was no evidence for a functional promoter between the p19 and cryIVD genes (Fig. 4 [pHT646] ). Finally, comparison between pHT646 and pHT649 indicated that the 373-bp EcoRV-BspHI fragment was required for significant CryIVD expression.
To follow the time course of CryIVD production during sporulation in B. thuringiensis subsp. israelensis, a transcriptional fusion was constructed (plasmid pHT693) and introduced in strain 4Q2-81. Results showed that transcription was induced about 9 h after the beginning of the sporulation process (data not shown). The transcriptional start sites were mapped by primer extension, using reverse transcriptase on total RNA extracted from 4Q2-72 cells. The cryIVD operon was expressed during mid-to late sporulation from two transcriptional start sites (Fig. 5, lanes 9 and 18) . The major transcript, initiated at a site designated PI, was detected 9 h after the onset of sporulation (Fig. 5, lanes 9) . The second and minor transcript, initiated at site PII, was detected 18 h after the entry into sporulation (Fig. 5A, lane 18) . The amount of transcript initiated at the PII site was less than 1% of that initiated at the PI site at 18 h. PI and PII were mapped 105 and 127 nucleotides upstream of the p19 ATG initiation codon (positions 977 and 955 in Fig. 1, respectively) . No other transcriptional start site was detected in front of the cryIVD gene by primer extension experiments with oligonucleotides hybridizing upstream from the ATG of the cryIVD coding sequence.
Sigma factor dependence in B. subtilis. The promoter region located upstream from the p19 gene contains regions similar to other promoter sequences of B. thuringiensis crystal protein genes (Fig. 6) . Sequences resembling the Ϫ10 and Ϫ35 regions of genes which are known to be recognized by RNA polymerase associated with the 35 factor were found 11 nucleotides upstream from PI, whereas the Ϫ10 and Ϫ35 sequences, located 10 nucleotides upstream from PII, matched with regions recognized by the RNA polymerase associated with the 28 factor. To test the 35 dependence and 28 dependence of the cryIVD transcriptional unit, the cryIVDЈ-lacZ transcriptional fusion was introduced as a single copy at the amyE locus in the chromosome of various sporulation mutants of B. subtilis (Table 1) , and ␤-galactosidase expression was assayed during sporulation. In a spo0A strain which is blocked early in sporulation (Fig. 7B) , there was no ␤-galactosidase activity (compared with that shown in Fig. 7A ). Thus, cryIVD gene transcription was sporulation dependent. Moreover, no transcription was detected either in E or in F mutant strains ( Fig. 7D and C, respectively) , indicating that E or F is necessary for the transcription of the cryIVD gene in B. subtilis. This should not be interpreted as a strict requirement for F but rather reflects the order of appearance of sigma factors during sporulation:
F activity is necessary for the sigma factor switch during sporulation. In contrast, there was no difference between G and K mutant strains and the wild type from t 0 to t 6 (Fig. 7E, F, and A, respectively) , indicating that these two factors are not necessary for early cryIVD transcription. However, in the K mutant strain the level of ␤-galactosidase activity measured late in sporulation (t 22 ) was eight times lower than that measured in the wild-type strain (53 and 392 Miller units per mg of protein, respectively) ( Fig. 7F and A) . These experiments strongly suggested that transcription of the cryIVD gene occurred in the mother cell during midsporulation under the control of E and that K may be responsible for the higher levels of activity detected at late sporulation stages. lane 0), and 3, 6, 9, and 18 h after the beginning of sporulation (lanes 3, 6, 9, and 18, respectively). Primer extension experiments were carried out with probe I (A) and probe II (B). For probe synthesis, single-stranded M13cryIVDЈ DNA was hybridized with primer 2: 5Ј-CTTCTCTCCCTTCTATGC-3Ј (complementary to the cryIVD coding sequence, nucleotides 1058 to 1074) (Fig. 1B) or primer 1: 5Ј-GGAATTGAGACTACA CAAC-3Ј (complementary to the cryIVD coding sequence, nucleotides 1185 to 1202) (Fig. 1B) and elongated by the Klenow fragment in the presence of [␣- 
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Operon organization of the p19, cryIVD, and p20 genes. Deletion analysis and sequence data (see below) strongly suggested that the p19 and cryIVD genes are organized as a single transcriptional unit. Primer extension experiments performed with an oligonucleotide complementary to the beginning of the cryIVD gene sequence showed no extension product less than 200 bp (data not shown), as expected in the case of a promoter located between the p19 and cryIVD genes. Adams et al. already suggested that the cryIVD and the p20 genes are organized in an operon (1) . To test this hypothesis, Northern blot experiments with total RNA extracted from 4Q2-72 cells harvested at various times during sporulation were performed. The RNA was probed for hybridization with sequences specific either for the p19 gene or for the cryIVD gene. In both cases (Fig. 8A and B, lanes 12) , a major transcript with a size of 2.7 kb and a minor one with a size of 4.1 kb, probably corresponding to the p19 and cryIVD single transcript and to the p19, cryIVD, and p20 single transcript, respectively, were detected. A probe specific for the p20 gene hybridized with two transcripts with sizes of 4.1 and 1.3 kb, respectively. The 1.3-kb transcript probably corresponds to the p20 mRNA.
DISCUSSION
This paper reports the nucleotide sequence of the DNA region located upstream from the cryIVD gene and the temporal regulation of cryIVD gene expression. CryIVA, CryIVB, CryIVD, and CytA account for about 5, 5, 35 , and 55% of the crystal polypeptides, respectively. Surprisingly, the expression levels of cryIVAЈ-lacZ, cryIVBЈ-lacZ (15) , and cryIVDЈ-lacZ (data not shown) did not reflect the synthesis rates of these toxins, since the three fusions exhibited similar levels of expression in B. thuringiensis. This discrepancy could be explained by the different stabilities of fusion mRNAs and fusion proteins. An alternative explanation is the synthesis in B. thuringiensis of cry gene mRNAs with different stabilities. Results suggest that the cryIVD operon is transcribed from 9 to 18 h after the beginning of the sporulation process and is 35 dependent and 28 dependent, as was already demonstrated for the cytA gene (41, 43) . Therefore, as shown by previous experiments, the 35 factor promotes the transcription of the cryIVA, cryIVB, cryIVD, and cytA genes during midsporulation, the transcription being relayed by the 28 Several experimental data indicated that the p19, cryIVD, and p20 genes are organized as a single transcriptional unit. Adams et al. (1) located two transcriptional start sites in front of the P20 ATG start codon which do not show consensus promoter sequences. We therefore propose that the site described by these authors corresponds to a cleavage site of the large 4.1-kb transcript of the entire operon, leading to two mRNAs with a size of 2.7 kb (corresponding to the p19 and cryIVD genes) and one mRNA with a size of 1.3 kb (corresponding to the p20 gene; see Results). Such mRNA cleavage in B. thuringiensis, in the case of cryIIIA gene expression, has already been suggested (3) .
The first ORF of the cryIVD operon, p19, shows significant similarity with the orf1 genes of the two B. thuringiensis subsp. kurstaki cryIIA and cryIIC operons, encoding a lepidopteran and dipteran-toxic CryIIA protein and a lepidopteran-toxic CryIIC protein, respectively. In addition, the CryIVD protein has regions which show similarity to both the CryIIA and CryIIC toxins (23) and shares weak but significant similarity with the other B. thuringiensis subsp. israelensis proteins which are toxic to dipteran larvae. On the basis of similar gene organization and sequence similarity, the CryIVD polypeptide could be classified as a CryII protein, according to the nomenclature of Höfte and Whiteley (21) , rather than as a CryIV toxin. We propose, therefore, to call this protein CryIID. Evolution from a common ancestor operon encoding three ORFs (orf1, orf2, and a cry gene) involving the following steps could be proposed: (i) loss of orf1 and orf2, which led to the monocistronic organization of the cryI, cryIII, and cryIV gene families, and (ii) loss of the orf2 gene, leading to the cryIVD operon, in contrast to the cryII family, which has conserved orf2. According to this hypothesis, the function of the Orf1 and the Orf2 proteins, if necessary, would have to be compensated for by other proteins.
B. thuringiensis subsp. israelensis crystals have a composite and complex structure, each crystal being composed of three inclusion types and surrounded by an envelope, according to Ibarra and Federici (22) . Synergistic interactions between the crystal components of B. thuringiensis subsp. israelensis have been shown to be responsible for their high levels of larvicidal activity (references 15, 32, and 46 and unpublished data). Moreover, the Orf2 of B. thuringiensis subsp. kurstaki is necessary for the crystallization of the CryIIA toxin (13) . Furthermore, the P20 protein acts as a chaperone protein to prevent proteolytic degradation of CytA in E. coli (40) and has to be coexpressed with CytA in B. thuringiensis subsp. israelensis to prevent cell lysis (reference 47 and unpublished data). Our results confirmed that the P20 polypeptide is not required for a high level of CryIVD expression in B. thuringiensis (12) and suggested that there was no obvious requirement of the p19 gene for the synthesis of the CryIVD protein in B. thuringiensis subsp. israelensis (see Results). Similarly, Crickmore and Ellar (13) and Wu et al. (45) demonstrated that the orf1 gene products were not necessary for the accumulation of both the CryIIA and CryIIC proteins in B. thuringiensis.
In conclusion, the role of the P19 polypeptide remains to be determined. We think it may be another chaperone protein. First, the gene encoding this protein is well conserved in all the cryII gene operons described. Second, the amino acid composition of the P19 protein is unusual: about 11.7% of the amino acids of P19 are cysteine residues. The C-terminal halves of the 130-kDa ␦-endotoxins are also rich in cysteine residues and are involved in the crystallization properties of these ␦-endotoxins (for a review, see reference 21). Since the CryIVD and CryII proteins do not have this C-terminal feature, it can been sug- FIG. 8 . Northern blot analysis of the mRNA of the cryIVD operon in B. thuringiensis subsp. israelensis. This operon is schematically represented at the top, the arrow showing the promoter region described in this paper. Total RNA isolated at different times (in hours) during sporulation (indicated by the lane numbers) was resolved in an agarose gel with the high-range scale RNA ladder (Bethesda Research Laboratories) as the size standard. The top of each gel and the RNA ladder fragment positions (in kilobases) are indicated to the left of each panel. The estimated sizes (in kilobases) of the different RNAs detected with the p19 probe (A), the cryIVD probe (B), and the p20 probe (C) are indicated to the right of each panel. The three specific probes used in the Northern blot experiments were obtained by PCR, using pEG217 as a template. For the p19-specific probe, the oligonucleotides 5Ј-CAATCACAATCTCCAATTGG-3Ј and 5Ј-TATTTGTTATGTAACAGGAG-3Ј were used to amplify a 604-bp fragment. For the cryIVD-specific probe, the oligonucleotides 5Ј-CGAACCTACTATTGCGCC-3Ј and 5Ј-TATAGGATGGACGCCACG-3Ј were used to amplify an 862-bp fragment. For the p20-specific probe, the oligonucleotides 5Ј-GAGCATAATTGATGACAG-3Ј and 5Ј-TTCACATTTATTACCCCC-3Ј were used to amplify a 712-bp fragment.
gested that the P19 protein plays a role in protein-protein interactions and may be necessary either to confer a particular lattice structure or to allow the coassembly of the CryIVD inclusion (type 2 inclusion [22] ) with the other B. thuringiensis subsp. israelensis inclusion types. In this case, the effect of the P19 deletion would be seen only in a strain producing all the B. thuringiensis subsp. israelensis toxins. The presence of another chaperone protein replacing the action of the P19 polypeptide (as for the orf2 gene in the CryB strain B. thuringiensis subsp. kurstaki [13] ) could explain why the P19 protein deletion has no detectable effect on the CryIVD production. Preliminary results revealed a DNA sequence in the B. thuringiensis genome which may have sequence similarity with the coding region of the P19 protein. Experiments are in progress to characterize this DNA sequence and to determine the role of the P19 polypeptide, if any, in the overall crystal assembly.
